228 related articles for article (PubMed ID: 10773326)
1. Utilization of poly(DL-lactide-co-glycolide) nanoparticles for preparation of mini-depot tablets by direct compression.
Murakami H; Kobayashi M; Takeuchi H; Kawashima Y
J Control Release; 2000 Jun; 67(1):29-36. PubMed ID: 10773326
[TBL] [Abstract][Full Text] [Related]
2. In vitro performance of carbamazepine loaded to various molecular weights of poly (D,L-lactide-co-glycolide).
Barakat NS; Radwan MA
Drug Deliv; 2006; 13(1):9-18. PubMed ID: 16401588
[TBL] [Abstract][Full Text] [Related]
3. Compressed biodegradable matrices of spray-dried PLGA microspheres for the modified release of ketoprofen.
Gavini E; Sanna V; Juliano C; Giunchedi P
J Microencapsul; 2003; 20(2):193-201. PubMed ID: 12554374
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of a model nucleoside (guanosine) release from biodegradable poly(DL-lactide-co-glycolide) microspheres: a delivery system for long-term intraocular delivery.
Chowdhury DK; Mitra AK
Pharm Dev Technol; 2000; 5(2):279-85. PubMed ID: 10810757
[TBL] [Abstract][Full Text] [Related]
5. Effect of formulation parameters on 2-methoxyestradiol release from injectable cylindrical poly(DL-lactide-co-glycolide) implants.
Desai KG; Mallery SR; Schwendeman SP
Eur J Pharm Biopharm; 2008 Sep; 70(1):187-98. PubMed ID: 18472254
[TBL] [Abstract][Full Text] [Related]
6. Sustained release microspheres of metoclopramide using poly(D,L-lactide-co-glycolide) copolymers.
Elkheshen SA; Radwan MA
J Microencapsul; 2000; 17(4):425-35. PubMed ID: 10898083
[TBL] [Abstract][Full Text] [Related]
7. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
Desai KG; Mallery SR; Schwendeman SP
Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
[TBL] [Abstract][Full Text] [Related]
8. Preparation of biodegradable microspheres of testosterone with poly(D,L-lactide-co-glycolide) and test of drug release in vitro.
Shen ZR; Zhu JH; Ma Z; Wang F; Wang ZY
Artif Cells Blood Substit Immobil Biotechnol; 2000 Jan; 28(1):57-64. PubMed ID: 10676577
[TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization, cytotoxicity and transfection efficiency of poly(DL-lactide-co-glycolide) and poly(DL-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA.
Basarkar A; Devineni D; Palaniappan R; Singh J
Int J Pharm; 2007 Oct; 343(1-2):247-54. PubMed ID: 17611054
[TBL] [Abstract][Full Text] [Related]
10. Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems.
Luan X; Bodmeier R
J Control Release; 2006 Jan; 110(2):266-272. PubMed ID: 16300851
[TBL] [Abstract][Full Text] [Related]
11. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
Witschi C; Doelker E
J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
[TBL] [Abstract][Full Text] [Related]
12. Clonazepam release from poly(DL-lactide-co-glycolide) nanoparticles prepared by dialysis method.
Nah JW; Paek YW; Jeong YI; Kim DW; Cho CS; Kim SH; Kim MY
Arch Pharm Res; 1998 Aug; 21(4):418-22. PubMed ID: 9875469
[TBL] [Abstract][Full Text] [Related]
13. Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method.
Murakami H; Kobayashi M; Takeuchi H; Kawashima Y
Int J Pharm; 1999 Oct; 187(2):143-52. PubMed ID: 10502620
[TBL] [Abstract][Full Text] [Related]
14. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
Duvvuri S; Janoria KG; Mitra AK
J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
[TBL] [Abstract][Full Text] [Related]
15. Study on in vitro release patterns of fentanyl-loaded PLGA microspheres.
Seo SA; Khang G; Rhee JM; Kim J; Lee HB
J Microencapsul; 2003; 20(5):569-79. PubMed ID: 12909542
[TBL] [Abstract][Full Text] [Related]
16. Stabilization of 10-hydroxycamptothecin in poly(lactide-co-glycolide) microsphere delivery vehicles.
Shenderova A; Burke TG; Schwendeman SP
Pharm Res; 1997 Oct; 14(10):1406-14. PubMed ID: 9358554
[TBL] [Abstract][Full Text] [Related]
17. In vitro drug release behavior of D,L-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion method.
Niwa T; Takeuchi H; Hino T; Kunou N; Kawashima Y
J Pharm Sci; 1994 May; 83(5):727-32. PubMed ID: 8071830
[TBL] [Abstract][Full Text] [Related]
18. Comparison of various injectable protein-loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices: in-situ-formed implant versus in-situ-formed microspheres versus isolated microspheres.
Jain RA; Rhodes CT; Railkar AM; Malick AW; Shah NH
Pharm Dev Technol; 2000; 5(2):201-7. PubMed ID: 10810750
[TBL] [Abstract][Full Text] [Related]
19. Effect of solvent on the preparation of surfactant-free poly(DL-lactide-co-glycolide) nanoparticles and norfloxacin release characteristics.
Jeon HJ; Jeong YI; Jang MK; Park YH; Nah JW
Int J Pharm; 2000 Oct; 207(1-2):99-108. PubMed ID: 11036235
[TBL] [Abstract][Full Text] [Related]
20. Development of implant tablet for a week-long sustained release.
Takahashi M; Onishi H; Machida Y
J Control Release; 2004 Nov; 100(1):63-74. PubMed ID: 15491811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]